- Covidien pharma president Wright bows out
Timothy Wright resigned as Covidien plc’s (NYSE:COV) senior vice president and president of its pharmaceuticals segment, effective Dec. 2, according to a Securities & Exchange Commission filing. Pharma CFO Matthew Harbaugh will serve as interim president of the segment until Wright’s successor is found, according to the filing.
Read more - LifeScience Alley and The BioBusiness Alliance of Minn. announce new leadership for strategic affiliation
LifeScience Alley and The BioBusiness Alliance of Minnesota announced new leadership for their recently established strategic affiliation. Dale Wahlstrom, who has been CEO of The BioBusiness Alliance of Minnesota since 2007, will now serve as president and CEO of both organizations. In other staffing moves to facilitate and maximize the organizations’ strategic affiliation, Liz Rammer, current executive vice president for LifeScience Alley, will serve as chief operations officer of LifeScience Alley, and Jeremy Lenz, current vice president of operations for The BioBusiness Alliance of Minnesota, will assume the role of chief operations officer of The BioBusiness Alliance of Minnesota. Both Rammer and Lenz will report to Wahlstrom.
Read more - Vascular Pathways hires Eugene Starr as president and CEO
Vascular Pathways Inc. announced that the company has elected Eugene (“Gene”) Starr as president, chief executive officer and member of its board of directors.
Read more - Metamark Genetics Inc. announces new CEO Mark Straley
Metamark Genetics Inc. announced the appointment of Mark Straley as the company’s president, CEO and newest member of its board of directors. Kenneth Weg, a Metamark co-founder who previously served as interim CEO, will continue to serve as chairman of the board.
Read more - Breathe Technologies appoints new CEO
Breathe Technologies announced the board of directors has appointed Lawrence Mastrovich as the new president and CEO.
Read more - NDS Surgical Imaging names Daniel Berry as CEO
NDS Surgical Imaging announced that Daniel Berry has been appointed CEO.
Read more - Foundation Medicine appoints Maureen Cronin as senior vice president of R&D
Foundation Medicine Inc. announced the appointment of Maureen Cronin, Ph.D., to the newly created position of senior vice president, research and product development. In this role, Cronin will lead the development and advancement of the company’s tests, which are being designed to enable personalized cancer treatment.
Read more - Cleveland Clinic IT executive joins medical data manager Explorys
Medical data management company Explorys Inc. has added a Cleveland Clinic information technology executive as its chief medical officer. Dr. Anil Jain will join Cleveland-based Explorys and also continue in his post at Cleveland Clinic.
Read more - RF Technologies names Paul Reynard senior vice president-sales and service
RF Technologies announced the hiring of Paul Reynard as senior vice president-sales and service.
Read more - Premier Research Adds Regulatory and Pediatric Expert to Senior Management Team
Premier Research Group Ltd. announced the appointment of Dr. Charlene Sanders to the position of vice president, global regulatory affairs and pediatric strategic consulting.
Read more - GenomeQuest Appoints Dr. Henk Heus to Scientific Lead of Personalized Medicine Program
GenomeQuest announced the appointment of Dr. Henk Heus to the newly established position of scientific Lead of GQ-PMR.
Read more - DiagnosisONE Names Robert Goodman as president
DiagnosisONE announced that it has named Robert Goodman as its new president.
Read more - Joseph Perrone Joins SRI International to direct molecular diagnostics and rare and neglected diseases group
SRI International announced that Joseph Perrone has joined its Center for Advanced Drug Research in Shenandoah Valley, Va.
Read more - Recombinant continues growth with new senior director of health systems solutions
Recombinant Data Corp. announced that Michael Kamerick, a leading expert in biomedical informatics, will join Recombinant as senior director of health systems solutions effective Dec. 1.
Read more - Marilyn Aardema joins BioReliance Corp. as chief scientific officer, toxicology
BioReliance announced today that Marilyn Aardema has been named chief scientific officer, toxicology, to provide oversight for all scientific and regulatory aspects of the company’s toxicology division.
Read more - Titan Spine Appoints vice president of marketing
Titan Spine announced the appointment of Andrew Shepherd as vice president of marketing.
Read more - diaDexus, Inc. Adds Two New Directors
diaDexus Inc. (OTC:DDXS) announced that its board of directors appointed two new independent directors, bringing the total number of directors to seven: Karen Drexler, who will chair the compensation committee, and Andrew Galligan, who will chair the audit committee.
Read more - EmSense appoints Scripps Research Institute’s Dr. John Polich to its science advisory board
EmSense Corp. announced the addition of Dr. John Polich to its science advisory board.
Read more
Material from MedCity News was used in this report
